Indocyanine green disappearance enhanced by prostaglandin E1 in patients with hepatic resection

Journal of Surgical Research

Volumn 66, Issue 1, 1996, Pages 64-68

  Tsukada, Kazuhiro ^a   Sakaguchi, Takeo ^a   Aono, Takashi ^a   Ishizuka, Dai ^a   Fujita, Nobuhiro ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; PROSTAGLANDIN E1;

ADULT; ARTICLE; CLINICAL ARTICLE; HUMAN; IMAGE ENHANCEMENT; LIVER BLOOD FLOW; LIVER CELL; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; PERFUSION PRESSURE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0030293995     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0373     Document Type: Article

References (33)

1. 1. Reemtsma, K., Hottinger, G. C., DeGraff, A. C., Jr., and Creech, O., Jr. The estimation of hepatic blood flow using indocyanine green. Surg. Gynecol. Obstet. 110: 353, 1960.
2. 2. Leevy, C. M., Mendenhall, C. L., Lesko, W., and Howard, M. M. Estimation of hepatic blood flow with indocyanine green. J. Clin. Invest. 41: 1169, 1962.
3. 3. Merkel, C., Bolognesi, M., Finucci, G. F., Angeli, P., Caregaro, L., Rondana, M., and Gatta, A. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis. J. Hepatol 9: 16, 1989.
4. 4. Hemming, A. W., Scudamore, C. H., Shackleton, C. R., Pudek, M., and Erb, S. R. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am. J. Surg. 163: 515, 1992.
5. 5. Jalan, R., Plevris, J. N., Jalan, A. R., Finlayson, N. D. C., and Hayes, P. C. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 58: 196, 1994.
6. 1. Transplantation 48: 447, 1989.
7. 1. Transplantation 54: 927, 1992.
8. 1 in liver transplantation. Hepatology 21: 366, 1995.
9. 1 on the function of organs in patients after hepatectomy. World J. Surg. 18(Suppl.): S36, 1994.
10. 1 in hepatectomized patients. J. Hep. Bil. Pancr. Surg. 4: 402, 1994.
11. 1 on ammonia concentration in blood of patients with hepatic resection. Dig. Dis. Sci. 41: 126, 1996.
12. 12. Sinclair, S. B., Greig, P. D., Blendis, L. M., Abecassis, M., Roberts, E. A., Phillips, M. J., Cameron, R., and Levy, G. A. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: A preliminary report. J. Clin. Invest. 84: 1063, 1989.
13. 13. Nishida, O., Moriyasu, F., Nakamura, T., Ban, N., Tamada, T., Kawasaki, T., and Uchino, H. Relationship between splenic and superior mesenteric venous circulation. Gastroenterology 98: 721, 1990.
14. 1 enhances hepatic portal venous flow by dilating the portal vascular bed in 70% hepatectomized dog. Gastroenterol. Jpn. 27: 341, 1992.
15. 1 on portal blood flow after partial hepatectomy in rats. Surg. Today 23: 277, 1993.
16. 1 following liver transplantation in pigs. Surg. Today 24: 621, 1994.
17. 1 in an experimental massive hepatic cell necrosis model. Hepatology 7: 1184, 1987.
18. 1 administaration in cirrhotic rats. Gastroenterology 105: 1483, 1993.
19. 19. Ohtake, M., Sandoh, N., Sakaguchi, T., Tsukada, K., and Hatakeyama, K. Enhancement of portal blood flow by ursodeoxycholic acid in partially hepatectomized rats. Surg. Today 26: 142, 1996.
20. 20. Aono, T., Tsukada, K., Sakaguchi, T., Ishiduka, D., Suzuki, T., and Hatakeyama, K. Utilization of low dose indocyanine green test for evaluating liver function. Acta Med. Biol. 42: 165, 1994.
21. 21. Ishigami, Y., Masuzawa, M., Miyoshi, E., Kato, M., Tamura, K., Kanda, M., Awazu, K., Taniguchi, K., Kurita, M., Hayashi, N., Kuwano, S., Fusamoto, H., and Kamada, T. Clinical applications of ICG finger monitor in patients with liver disease. J. Hepatol. 19: 232, 1993.
22. 22. Nakayama, M., Kanaya, N., Fujita, S., and Namiki, A. Effects of ephedrine on indocyanine green clearance during spinal anesthesia: Evaluation by the finger piece method. Anesth. Analg. 77: 947, 1993.
23. 1 increases indocyanine green disappearance rate in patients with chronic liver disease. J. Int. Med. Res. 23: 299, 1995.
24. 24. Aono, T., Tsukada, K., Sakaguchi, T., Koyama, S., Suzuki, T., and Hatakeyama, K. Noticeable hyperbilirubinemia following major hepatectomy in patients with biliary tract carcinoma. Arch. Jpn. Chir. 64: 64, 1995.
25. 25. Aono, J., Takeda, A., Ueda, W., and Hirakawa, M. Interaction of halothane and PGE1 on ICG excretion. Masui 39: 588, 1990. [In Japanese]
26. 26. Gelman, S. I. Disturbances in hepatic blood flow during anesthesia and surgery. Arch. Surg. 111: 881, 1976.
27. 1α on isolated vascular smooth muscle. Am. J. Physiol. 213: 725, 1967.
28. 1 on fractional distribution of cardiac output and organ blood flow in man: A simultaneous and non-invasive determination using double dose thallium-201 scintigraphy. Cardiovasc. Res. 18: 657, 1984.
29. 29. Bhathal, P. S., and Grossman, H. J. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J. Hepatol. 1: 325, 1985.
30. 30. Shibayama, Y., and Nakata, K. Localization of increased hepatic vascular resistance in liver cirrhosis. Hepatology 5: 643, 1985.
31. 31. Matsumata, T., Kanematsu, T., Yoshida, Y., Furuta, T., Yanaga, K., and Sugimachi, K. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J. Surg. 11: 678, 1987.
32. 1 in man. Acta Physiol. Scand. 64: 332, 1965.
33. 33. Eklund, B., and Carlson, L. A. Central and peripheral circulatory effects and metabolic effects of different prostaglandins given iv to man. Prostaglandins 20: 333, 1980.